iShares Biotechnology ETF (IBB)
NASDAQ: IBB
· Real-Time Price · USD
138.38
-0.38 (-0.27%)
At close: Aug 18, 2025, 3:59 PM
139.20
0.60%
After-hours: Aug 18, 2025, 06:05 PM EDT
-0.27% (1D)
| Bid | 138.41 |
| Market Cap | 9.64B |
| AUM | 5.57B |
| NAV | 137.13 |
| EPS (ttm) | 6.62 |
| PE Ratio (ttm) | 20.90 |
| Shares Out | 69.7M |
| Inception Date | Feb 5, 2001 |
| Ask | 139.2 |
| Volume | 1.13M |
| Open | 139.06 |
| Previous Close | 138.76 |
| Day's Range | 138.28 - 139.68 |
| 52-Week Range | 107.43 - 150.57 |
| Holdings | 252 |
| Expense Ratio | 0.44% |
About IBB
The iShares Biotechnology ETF seeks to track the investment results of an index composed of U.S.-listed equities in the biotechnology sector.
Asset Class Equity
Ticker Symbol IBB
Inception Date Feb 5, 2001
Provider Blackrock
Website Fund Home Page
Exchange NASDAQ
Top 10 Holdings 47.84% of assets
| Name | Symbol | Weight |
|---|---|---|
| Gilead Sciences, Inc... | GILD | 7.75% |
| Amgen Inc. | AMGN | 7.22% |
| Regeneron Pharmaceut... | REGN | 6.46% |
| Vertex Pharmaceutica... | VRTX | 6.33% |
| Alnylam Pharmaceutic... | ALNY | 6.05% |
| Iqvia Holdings Inc. | IQV | 3.56% |
| Mettler-toledo Inter... | MTD | 2.98% |
| Argenx Se | ARGX | 2.75% |
| Insmed Incorporated | INSM | 2.49% |
| Natera, Inc. | NTRA | 2.25% |
Dividends Dividend Yield 0.38%
| Ex-Dividend | Amount | Payment Date |
|---|---|---|
| Mar 18, 2025 | $0.1212 | Mar 21, 2025 |
| Dec 17, 2024 | $0.0624 | Dec 20, 2024 |
| Sep 25, 2024 | $0.2005 | Sep 30, 2024 |
| Mar 21, 2024 | $0.1260 | Mar 27, 2024 |
| Dec 20, 2023 | $0.1240 | Dec 27, 2023 |
